Structural and interaction analysis of human lipocalin‐type prostaglandin D synthase with the poorly water‐soluble drug NBQX
The FEBS Journal · 2023
DOI: 10.1111/febs.16791 ↗Kurz gefasst
Fachartikel in der Zeitschrift The FEBS Journal, 2023. Verfasst von Yuya Miyamoto und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Biological Macromolecules, Graduate School of Life and Environmental Sciences, Osaka Prefecture University, Sakai, Japan. Hauptthemen laut MEDLINE: Water, Lipocalins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Lipocalin‐type prostaglandin D synthase (L‐PGDS) is a secretory lipid‐transporter protein that was shown to bind a wide variety of hydrophobic ligands in vitro . Exploiting this function, we previously examined the feasibility of using L‐PGDS as a novel delivery vehicle for poorly water‐soluble drugs. However, the mechanism by which human L‐PGDS binds to poorly water‐soluble drugs is unclear. In this study, we determined the solution structure of human L‐PGDS and investigated the mechanism of L‐PGDS binding to 6‐nitro‐7‐sulfamoyl‐benzo[f]quinoxalin‐2,3‐dione (NBQX), an α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazole‐propionic acid receptor antagonist. NMR experiments showed that human L‐PGDS has an eight‐stranded antiparallel β‐barrel structure that forms a central cavity, a short 3 10 ‐helix and two α‐helices. Titration with NBQX was monitored using 1 H‐ 15 N HSQC spectroscopy. At higher NBQX concentrations, some cross‐peaks of the protein exhibited fast‐exchanging shifts with a curvature, indicating at least two binding sites. These residues were located in the upper portion of the cavity. Singular value decomposition analysis revealed that human L‐PGDS has two NBQX binding sites. Large chemical shift changes were observed in the H2‐helix and A‐, B‐, C‐, D‐, H‐ and I‐strands and H2‐helix upon NBQX binding. Calorimetric experiments revealed that human L‐PGDS binds two NBQX molecules with dissociation constants of 46.7 μ m for primary binding and 185.0 μ m for secondary binding. Molecular docking simulations indicated that these NBQX binding sites are located within the β‐barrel. These results provide new insights into the interaction between poorly water‐soluble drugs and human L‐PGDS as a drug carrier.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Biological Macromolecules, Graduate School of Life and Environmental Sciences, Osaka Prefecture University, Sakai, Japan.
- Japan Society for the Promotion of Science, Chiyoda-ku, Japan.
- Laboratory of Biophysical Chemistry, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Japan.
ORCID-Profile: Yuya Miyamoto, Takashi Inui
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Miyamoto, Y., Nakatsuji, M., Yoshida, T., Ohkubo, T., & Inui, T. (2023). Structural and interaction analysis of human lipocalin‐type prostaglandin D synthase with the poorly water‐soluble drug NBQX. The FEBS Journal. https://doi.org/10.1111/febs.16791
Vancouver
Miyamoto Y, Nakatsuji M, Yoshida T, Ohkubo T, Inui T. Structural and interaction analysis of human lipocalin‐type prostaglandin D synthase with the poorly water‐soluble drug NBQX. The FEBS Journal. 2023. doi:10.1111/febs.16791
BibTeX
@article{Miyamoto2023,
author = {Miyamoto, Yuya and Nakatsuji, Masatoshi and Yoshida, Takuya and Ohkubo, Tadayasu and Inui, Takashi},
title = {Structural and interaction analysis of human lipocalin‐type prostaglandin D synthase with the poorly water‐soluble drug NBQX},
journal = {The FEBS Journal},
year = {2023},
doi = {10.1111/febs.16791}
}
EUVIMED